Insider Transactions

Richard Glasier, a director atCarnival Corp (CCL), recently picked up 10,000 shares. The purchase came to just over $140,000, and increased the director’s stake by 23 percent. This marks the second insider buy of 2020, following a 1.25 million share buy from another director back in early April. Insiders were last sellers in 2019, at prices 70-75 percent higher than where shares currently trade. Shares of the cruise line company have doubled off their March lows. They are still down two-thirds over ...
Read More About This

Lew Jacobs, a director atCitigroup (C), recently added 10,000 shares. The buy came to just over $440,000, and increased the director’s stake by 77 percent. He now owns over 22,900 shares. The trade marks the first move by insiders since August 2019. Insiders have mostly been sellers in the past two years, but have been inactive for a prolonged time. The last sales were at prices 30-37 percent higher than where shares currently trade. The big banks have had to contend with ...
Read More About This

Luke Evnin, a director atOncorus (ONCR), recently added 151,225 shares to his holdings. The value came to over $2.2 million. But he’s hardly alone. A number of funds with substantial holdings have also been adding to their stake here. That includes a 1 million share buy from Deerfield Management, and a 325,000 share buy from Gadicke Ansbert, a major holder. The buys occurred in early October, just a few weeks after the company went public. Oncorus is a clinical-stage biotech firm. Their focus ...
Read More About This

Daniel Solomita, President and CEO ofLoop Industries (LOOP), recently bought 10,000 shares. The buy increased his stake by 5 percent, and came to a cost of just over $73,000. He was joined by the company CFO, buying 5,000 shares. Two directors have also been buyers in recent days, each picking up 10,000 shares in the low $8 range. This cluster of insider buying has occurred as shares have been cut nearly in half in the past month. The last insider activity occurred ...
Read More About This

Ares Trading, already a major holder inPrecigen (PGEN), recently added another $25 million investment. At that price, the company was able to pick up 6,758,400 shares. That’s a 32 percent increase to the fund’s stake in the company. The move dwarfs the insider sales in the past month from company insiders. The buy comes as shares of the company have dropped from $15 to under $4 in the past two years. Insiders, including Ares Trading, own over 15 percent of shares. Precigen ...
Read More About This

Timothy Springer, a director and major owner atSelecta Biosciences (SELB), recently bought 3,185,394 shares of the company. That trade came to over $5.4 million. The buy increased his total holdings to just over 16.05 million shares. Another director made a 50,000 share buy at the start of October as well. There have been some insider sales in the past year, but they have been dwarfed by insider buys. Insiders own 17 percent of all shares of the immunogenetics company. Shares of the ...
Read More About This

Richard Anderson, a director atMedtronic PLC (MDT), recently added 4,607 shares. The buy came to a total purchase price of nearly $51,000, and increased the director’s stake by 4.4 percent. This is the second insider buy of 2020, following a buy from the company CEO back in February. Insiders have been a mix of buyers and sellers this year. The share price of the company has held up relatively well in the past year. Although sales and earnings are slightly off in ...
Read More About This

James Filler, a major owner atCentury Bancorp (CNBKA), recently added 1,002 shares to his stake. A mere 0.12 percent increase, the $69,000 buy increased his holdings to over 848,000 shares. This follows on top of some small share buys from company executives earlier in the month, although Filler has been the major buyer of shares in the past year. The Massachusetts based-bank has 27 offices in the state. Shares have shed 21 percent in the past year, as the decline in interest ...
Read More About This